30
Views
0
CrossRef citations to date
0
Altmetric
Letter in Reply

In reply to: Significant heterogeneity of published literature comparing radiofrequency ablation versus stereotactic body radiation therapy for hepatocellular carcinoma

ORCID Icon & ORCID Icon
Pages 289-290 | Received 15 Jan 2023, Accepted 31 Jan 2023, Published online: 04 Apr 2023

References

  • Malik A , JairamMP, ChowRet al. Significant heterogeneity of published literature comparing radiofrequency ablation versus stereotactic body radiation therapy for hepatocellular carcinoma. Future Oncol. doi: 10.2217/fon-2022-0713 (2023) ( Epub ahead of print).
  • Zhang H , ChangN, HanTet al. Radiofrequency ablation versus stereotactic body radiotherapy for hepatocellular carcinoma: a meta-analysis. Future Oncol.17(30), 4027–4040 (2021).
  • Zhou B , ChenX, ShiJet al. Meta-analysis of rates and software implementation. Chin. J. Evidence Based Med.14(8), 1009–1016 (2014).
  • Spineli LM , PandisN. Problems and pitfalls in subgroup analysis and meta-regression. Am. J. Orthod. Dentofacial Orthop.158(6), 901–904 (2020).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.